AQP5
Aquaporin-5
Also known as: AQP5_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P55064
- Gene
- AQP5
- Ensembl
- ENSG00000161798
- Chromosome
- 12
- Canonical length
- 265 aa
- Protein class
- Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters
- Subcellular location
- Plasma membrane
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
Aquaporin 5 (AQP5) is a water channel protein. Aquaporins are a family of small integral membrane proteins related to the major intrinsic protein (MIP or AQP0). Aquaporin 5 plays a role in the generation of saliva, tears and pulmonary secretions. AQP0, AQP2, AQP5, and AQP6 are closely related and all map to 12q13. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
265 residues, UniProt reviewed canonical sequence.
>P55064|AQP5
1 MKKEVCSVAF LKAVFAEFLA TLIFVFFGLG SALKWPSALP TILQIALAFG LAIGTLAQAL
61 GPVSGGHINP AITLALLVGN QISLLRAFFY VAAQLVGAIA GAGILYGVAP LNARGNLAVN
121 ALNNNTTQGQ AMVVELILTF QLALCIFAST DSRRTSPVGS PALSIGLSVT LGHLVGIYFT
181 GCSMNPARSF GPAVVMNRFS PAHWVFWVGP IVGAVLAAIL YFYLLFPNSL SLSERVAIIK
241 GTYEPDEDWE EQREERKKTM ELTTRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against AQP5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 6
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 586 nTPM
Expression across tissuesHPA
Tissue
- salivary gland: 586 nTPM
- testis: 211 nTPM
- skin: 107 nTPM
- stomach: 49 nTPM
- breast: 16 nTPM
- esophagus: 16 nTPM
Single-cell type
- late spermatids: 6,778 nCPM
- early spermatids: 1,517 nCPM
- late primary spermatocytes: 1,509 nCPM
- respiratory secretory cells: 1,449 nCPM
- ocular epithelial cells: 953 nCPM
- respiratory basal cells: 756 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- midbrain: 5.5 nTPM
- thalamus: 5.2 nTPM
- basal ganglia: 5.1 nTPM
- cerebellum: 4.2 nTPM
- medulla oblongata: 4.2 nTPM
- pons: 4 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about AQP5.
Disease | AllUniProt
Conditions AQP5 is implicated in, by any mechanism.
- Keratoderma, palmoplantar, Bothnian type (PPKB) MIM:600231
Disease | GeneticClinVar
5 pathogenic / likely-pathogenic of 87 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Palmoplantar keratoderma, Bothnian type
Disease | ImmuneIEDB
Conditions an epitope on AQP5 was assayed in.
- Sjogren's syndrome B cell
- autoimmune disease B cell
- systemic lupus erythematosus B cell
- rheumatoid arthritis B cell
Disease | AutoantibodyPubMed
Conditions in which antibodies against AQP5 are reported. Each links to that disease's full target list.
ReferencesPubMed · IEDB
Publications for AQP5 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
14 publications
- Detection of autoantibodies against aquaporin-5 in the sera of patients with primary Sjögren's syndrome.
2016 · Immunol Res · RCR 1.9 · 42 citations - Autoantibody against aquaporin-5 may be a new diagnostic biomarker for primary Sjögren's syndrome.
2024 · Clin Rheumatol · RCR 1.8 · 7 citations - Antibodies to aquaporins are frequent in patients with primary Sjögren's syndrome.
2017 · Rheumatology (Oxford) · RCR 1.6 · 36 citations - Anti-aquaporin-5 and anti-poly-U-binding-factor-60kDa protein antibodies in primary Sjögren's disease patients: preliminary data and correlation with disease activity indices.
2024 · Clin Exp Rheumatol · RCR 1.6 · 7 citations - Associations of Anti-Aquaporin 5 Autoantibodies with Serologic and Histopathological Features of Sjögren's Syndrome.
2019 · J Clin Med · RCR 1.4 · 24 citations
Show 9 more
- Functional Epitopes for Anti-Aquaporin 5 Antibodies in Sjögren Syndrome.
2017 · J Dent Res · RCR 0.9 · 19 citations - Detection of Autoantibodies against Aquaporin-1 in the Sera of Patients with Primary Sjögren's Syndrome.
2017 · Immune Netw · RCR 0.9 · 17 citations - Induction of Anti-Aquaporin 5 Autoantibody Production by Immunization with a Peptide Derived from the Aquaporin of Prevotella melaninogenica Leads to Reduced Salivary Flow in Mice.
2021 · Immune Netw · RCR 0.6 · 7 citations - Efficient generation of a stable CHO-K1 cell line overexpressing the human water channel aquaporin-5 as tool to generate therapeutic antibodies.
2024 · Sci Rep · RCR 0.4 · 1 citations - [A case of neuromyelitis optica spectrum disorder (NMOSD) with Sjögren's syndrome manifested only brain involvement by preceding parotitis].
2017 · Rinsho Shinkeigaku · RCR 0.2 · 3 citations - Determination of Anti-aquaporin 5 Autoantibodies by Immunofluorescence Cytochemistry.
2019 · Methods Mol Biol · RCR 0.1 · 1 citations - Requirements for anti-aquaporin 5 autoantibody production in a mouse model.
2023 · Mol Oral Microbiol - CLIP2: a novel functional player in AQP5 trafficking dynamics and implications for Sjögren's disease.
2025 · Cell Commun Signal - Mechanism exploration of Jiajian Yiguan decoction in treating Sjögren's syndrome.
2026 · J Ethnopharmacol
Reference: B cellIEDB
3 publications
- Associations of Anti-Aquaporin 5 Autoantibodies with Serologic and Histopathological Features of Sjögren's Syndrome.
2019 · J Clin Med · RCR 1.4 · 24 citations - Functional Epitopes for Anti-Aquaporin 5 Antibodies in Sjögren Syndrome.
2017 · J Dent Res · RCR 0.9 · 19 citations - Peptide microarray-based characterization of antibody responses to host proteins after bacille Calmette-Guérin vaccination.
2017 · Int J Infect Dis · RCR 0.7 · 19 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.06
- gnomAD pLI
- 0.05
- gnomAD missense Z
- 0.38
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- camera-type eye morphogenesis
- carbon dioxide transport
- cellular hypotonic response
- odontogenesis
- pancreatic juice secretion
- protein homotetramerization
- saliva secretion
- water transport
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of AQP5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AQP5 as an antibody target. Whether an autoantibody or antibody against AQP5 could matter depends on whether native AQP5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AQP5 is annotated at the cell surface, where native AQP5 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label AQP5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...